GESTASYONEL TROFOBLASTİK HASTALIKLARA GÜNCEL YAKLAŞIM CONTEMPORARY
Gestasyonel trofoblastik hastalık (GTH), değişken derecede lokal invazyon ve metastaz gösterebilen komplet ve parsiyel hidatiform mol, invaziv mol, koryokarsinom, plasental site trofoblastik tümör (PSTT) ve epiteloid trofoblastik tümörü içeren birbiriyle ilişkili tümör grubudur. Gestasyonel trofoblastik neoplazi (GTN) invazyon ve metastaz gösterebilen tedavi edilmezse ölümcül olabilen bir hastalıktır. Bu grupta invazif mol, koryokarsinom ve PSTT bulunur. Bu derlemede amacımız güncel literatür ışığında GTH’ın tanı, yönetimi ve takibini tartışmaktır.
TREATMENT OF GESTATİONAL TROPHOBLASTİC DİSEASE
Gestational trophoblastic disease (GTD) includes a spectrum of interrelated tumors, including complete and partial hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor that have varying propensities for local invasion and metastasis. Futhermore, invasive mole, choriocarcinoma and PSTT are classified as gestational trophoblastic neoplasia, which can progress, invade, metastasize, and lead to death if left untreated. In this review, our aim is to discuss diagnosis, management and follow-up of the GTD in light of the current literature.
___
- 1. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic
disease. Lancet. 2010 Aug 28;376:717-29
- 2. Lurain JR. Gestational trophoblastic disease I: epidemiology,
pathology, clinical presentation and diagnosis
of gestational trophoblastic disease, and management
of hydatidiform mole. Am J Obstet Gynecol. 2010
Dec;203(6):531-9.
- 3. Dhanda S, Ramani S, Th akur M. Gestational trophoblastic
disease: a multimodality imaging approach with
impact on diagnosis and management. Radiol Res Pract.
2014;2014:842751.
- 4. Tse KY, Chan KK, Tam FK, Ngan YH. Current management
of gestational trophoblastic disease. Obstetrics,
Gynaecology and Reproductive Medicine 2014; 25:1, 12-21.
- 5. Mangili G, Lorusso D, Brown J, Pfisterer J, Massuger L,
Vaughan M et al. Trophoblastic disease review for diagnosis
and management: a joint report from the International
Society for the Study of Trophoblastic Disease, European
Organisation for the Treatment of Trophoblastic
Disease, and the Gynecologic Cancer InterGroup. Int J
Gynecol Cancer. 2014 Nov;24:109-16.
- 6. Parazzini F, La Vecchia C, Pampallona S. Parental age and
risk of complete and partial hydatiform mole. Br J Obstet
Gynaecol 1986;93:582-85.
- 7. Parazinni F, La Vecchia C, Mangili G, Caminiti C, Negri
E, Cecchetti G et al. Dietary factors and risk of trophoblastic
disease. Am J Obstet Gynecol 1988;158:93.
- 8. Ulker V, Gurkan H, Tozkir H, Karaman V, Ozgur H, Numanoglu
C et al. Novel NLRP7 mutations in familial recurrent
hydatidiform mole: are NLRP7 mutations a risk
for recurrent reproductive wastage? Eur J Obstet Gynecol
Reprod Biol. 2013;170: 88–192.
- 9. Parazzini F, Cipriani S, Mangili G, Garavaglia E, Guarnerio
P, Ricci E et al. Oral contraceptives and risk of gestational
trophoblastic disease. Contraception. 2002;65(6):425-7.
- 10. Froeling FE, Seckl MJ. Gestational trophoblastic tumours:
an update for 2014. Curr Oncol Rep. 2014 Nov;16(11):408.
- 11. Loukovaara M, Pukkala E, Lehtovirta P, Leminen A.
Epidemiology of hydatidiform mole in Finland, 1975 to
2001. Eur J Gynaecol Oncol 2005;26(2):207–8.
- 12. Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS.
Gestational trophoblastic disease. Clin Obstet Gynecol
2007;50(1):112–22.
- 13. Berkowitz RS, Goldstein DP. Current management of
gestational trophoblastic diseases. Gynecol Oncol 2009
Mar;112(3):654-62.
- 14. Ozalp S, Telli E, Oge T, Tulunay G, Boran N, Turan T.
Multicenter Analysis of Gestational Trophoblastic Neoplasia
in Turkey. Asian Pac J Cancer Prev 2014;15:3625-28.
- 15. Berkowitz RS, Goldstein. Gestational trophoblastic disease.
In: Berek JS, Hacker NF. Gynaecology Oncology. 5th
ed. Philadelphia: Williams and Wilkins; 2014.
- 16. Mangili G, Giorgione V, Gentile C, Bergamini A, Pella F,
Almirante G, Candiani M. Hydatidiform mole: age-related
clinical presentation and high rate of severe complications
in older women. Acta Obstet Gynecol Scand.
2014;93(5):503-7.
- 17. Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz
NS, Moron AF et al. Changing presentation of complete
hydatidiform mole at the New England Trophoblastic
Disease Center over the past three decades: does early diagnosis
alter risk for gestational trophoblastic neoplasia?
Gynecol Oncol. 2015 Jul;138(1):46-9.
- 18. Elias K, Shoni M, Bernstein M, Goldstein D, Berkowitz
R. Complete hydatidiform mole in women aged 40 to 49
years. J Reprod Med. 2012 May-Jun;57(5-6):254-8.
- 19. Alhamdan D, Bignardi T, Condous G. Recognising gestational
trophoblastic disease. Best Pract Res Clin Obstet
Gynaecol 2009;23:565–573.
- 20. Taylor KJW, Schwartz PE, Kohorn EI. Gestational trophoblastic
neoplasia: diagnosis with Doppler US. Radiology
1987;165:445–448.
- 21. Shimamoto K, Sakuma S, Ishigaki T. Intratumoral blood
fl ow: evaluation with color Doppler echography. Radiology
1987;165 683–685.
- 22. Desai RK, Desberg AL. Diagnosis of gestational trophoblastic
disease: value of endovaginal color fl ow
Doppler sonography. Case report. Am J Radiol October
1991;157:787–788.
- 23. Shanbhogue AK, Lalwani N, Menias CO. Gestational
trophoblastic disease. Radiol Clin North Am. 2013
Nov;51(6):1023-34
- 24. Bolze PA, Attia J, Massardier J, Seckl MJ, Massuger L, van
Trommel N et al. Formalised consensus of the European
Organisation for Treatment of Trophoblastic Diseaseson
management of gestational trophoblastic diseases. Eur J
Cancer. 2015 Jun 16. pii: S0959-8049(15)00494-3.